Phospholipase A2 is not responsible for lysophosphatidylcholine- induced damage in cardiomyocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 275, Issue 5 44-5, 1998, Pages

  Chen, Min ^a   Xiao, Chun Yang ^a   Hashizume, Hiroko ^a   Abiko, Yasushi ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Creatine kinase; Intracellular calcium; Nonesterified fatty acids

Indexed keywords

CREATINE KINASE; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; 7,7 DIMETHYL 5,8 EICOSADIENOIC ACID; 7,7-DIMETHYL-5,8-EICOSADIENOIC ACID; CALCIUM; PHOSPHODIESTERASE INHIBITOR; PHOSPHOLIPASE A; UNSATURATED FATTY ACID;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; HEART MUSCLE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL CULTURE; CELL SIZE; DRUG EFFECT; HEART MUSCLE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM; CELL SIZE; CELLS, CULTURED; FATTY ACIDS, UNSATURATED; LYSOPHOSPHATIDYLCHOLINES; MALE; MYOCARDIUM; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASES A; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 0031755113     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.275.5.h1782     Document Type: Article

References (24)

1. 2+-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes. Br. J. Pharmacol. 118: 865-870, 1996.
2. 2+-independent cellular injury attenuated by d-propranolol in rat cardiomyocytes. Life Sci. 60: 57-62, 1997.
3. Chien, K. R., A. Sen, R. Reynolds, A. Chang, Y. Kim, M. D. Gunn, L. M. Buja, and J. T. Willerson. Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion. Correlation with the progression of cell injury. J. Clin. Invest. 75: 1770-1780, 1985.
4. Corr, P. B., D. W. Snyder, B. I. Lee, R. W. Gross, C. R. Keim, and B. E. Sobel. Pathophysiological concentrations of lysophosphatides and the slow response. Am. J. Physiol. 243 (Heart Circ. Physiol. 12): H187-H195, 1982.
5. Fautin, D. G. Biomedical Importance of Marine Organisms. San Francisco, CA: California Academy of Sciences, 1988, p.133.
6. Fink, K. L., and R. W. Gross. Modulation of canine myocardial sarcolemmal membrane fluidity by amphiphilic compounds. Circ. Res. 55: 585-594, 1984.
7. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
8. Hashizume, H., K. Akiyama, and Y. Abiko. Effects of antiischemic drugs on veratridine-induced hypercontracture in rat cardiac myocytes. Eur. J. Pharmacol. 271: 1-8, 1994.
9. 2 from transplant recipients suffering from end-stage ischemic heart disease. Circ. Res. 70: 486-495, 1992.
10. + exchange inhibition protects against mechanical, ultrastructural, and biochemical impairment induced by low concentrations of lysophosphatidylcholine in isolated rat hearts. Circ. Res. 80: 95-102, 1997.
11. Hoque, A. N. E., N. Hoque, H. Hashizume, and Y. Abiko. A study on dilazep. II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart. Jpn. J. Pharmacol. 67: 233-241, 1995.
12. 2-induced cell damage. J. Pharmacol. Exp. Ther. 277: 207-211, 1996.
13. Katz, A. M., and F. C. Messineo. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ. Res. 48: 1-16, 1981.
14. 2 inhibition by alkylbenzoylacrylic acids. Biochem. Pharmacol. 44: 805-813, 1992.
15. 1 cell. Effects of manoalide, 7,7-dimethyl-5,8-eicosadienoic acid, and p-bromophenacyl bromide. J. Biol. Chem. 264: 8520-8528, 1989.
16. Man, R. Y. K., A. A. A. Kinnaird, I. Bihler, and P. C. Choy. The association of lysophosphatidylcholine with isolated cardiac myocytes. Lipids 25: 450-454, 1990.
17. 2+ accumulation in rat cardiac myocytes. Am. J. Physiol. 244 (Heart Circ. Physiol. 13): H32-H38, 1983.
18. Sen, A., J. C. Miller, R. Reynolds, J. T. Willerson, L. M. Buja, and K. R. Chien. Inhibition of the release of arachidonic acid prevents the development of sarcolemmal membrane defects in cultured rat myocardial cells during adenosine triphosphate depletion. J. Clin. Invest. 82: 1333-1338, 1988.
19. Shaikh, N. A., and E. Downar. Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis. Circ. Res. 49: 316-325, 1981.
20. Snyder, D. W., Jr., W. A. Crafford, J. L. Glashow, D. Rankin, B. E. Sobel, and P. B. Corr. Lysophosphoglycerides in ischemic myocardium effluents and potentiation of their arrhythmogenic effects. Am. J. Physiol. 241 (Heart Circ. Physiol. 10): H700-H707, 1981.
21. 2-dependent signalling in the heart. Cardiovasc. Res. 30: 518-529, 1995.
22. Van Den Bosch, H. Intracellular phospholipases A. Biochim. Biophys. Acta 604: 191-246, 1980.
23. 2+-overload in isolated cardiomyocytes and effect of cytoprotective drugs. J. Mol. Cell. Cardiol. 24: 977-988, 1992.
24. 2 in canine myocardium. J. Biol. Chem. 260: 7295-7303, 1985.